Details for New Drug Application (NDA): 209685
✉ Email this page to a colleague
The generic ingredient in ATOVAQUONE is atovaquone; proguanil hydrochloride. There are sixteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the atovaquone; proguanil hydrochloride profile page.
Summary for 209685
Tradename: | ATOVAQUONE |
Applicant: | Glenmark Speclt |
Ingredient: | atovaquone |
Patents: | 0 |
Suppliers and Packaging for NDA: 209685
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ATOVAQUONE | atovaquone | SUSPENSION;ORAL | 209685 | ANDA | Northstar Rx LLC | 16714-900 | 16714-900-01 | 210 mL in 1 BOTTLE (16714-900-01) |
ATOVAQUONE | atovaquone | SUSPENSION;ORAL | 209685 | ANDA | Glenmark Pharmaceuticals Inc., USA | 68462-421 | 68462-421-21 | 210 mL in 1 BOTTLE (68462-421-21) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 750MG/5ML | ||||
Approval Date: | Nov 21, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription